Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

1. The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy

   Ying Zhang, V. Akhil, Ho Seong Seo +8

   МақолаCancer Research and TreatmentsTheranostics20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.000480

2. Molecular dynamics insights into the redox effects on PD-1/PD-L1 and PD-1/PD-L2 interactions

   Rasulbek Mashalov, Zulfizar Toshpulatova, Zhitong Chen +1

   МақолаPlasma Applications and DiagnosticsScientific Reports20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.008635

3. A comprehensive review of immunotherapy in gastrointestinal tumors with a focus on the role of combination therapy with PARP inhibitors

   Saade Abdalkareem Jasim, Jitendra Gupta, Subasini Uthirapathy +7

   Шарҳ мақолаCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000180